← Leaderboards
Yi Xing
University Of Iowa
$14,026,823
Attributed
$29,857,302
Total exposure
16
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.2M · FY2010–25$10M$7.5M$5M$2.5M$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$29,857,302 · 16
By mechanism
R01$21,740,682 · 10
U01$6,293,302 · 2
R21$1,254,472 · 3
R56$568,846 · 1
Top collaborators
- Owen N Witte11 shared
- Douglas L. Black10 shared
- Gay Miriam Crooks6 shared
- Douglas C Wallace6 shared
- Beverly L Davidson5 shared
- Liming Pei5 shared
- Kathrin Plath5 shared
- Robert M Prins5 shared
Most similar at University Of Iowa
Same institution · by research overlap
- Long-Sheng Song$13,907,411
- George J Weiner$29,916,936
- Beverly L Davidson$40,254,264
- Geoffrey McLennan$5,088,107
- Bennett David Elzey$2,004,599
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsAlternative SplicingData SetRna SplicingGenesTranscriptome SequencingMrna PrecursorProteinsProtein IsoformsAffectTissuesExonsEventPatternGene ExpressionMessenger RnaTranscriptRegulationInsightVariantBioinformaticsHuman DiseaseCell TypeMalignant Neoplasms
Grant awards (59)
Mitochondrial dysfunction driven by splicing factor mutations in MDS$3,227,502
R01 · FY2025 · DK
Comprehensive identification and functional study of Esrp-regulated isoforms during epithelial-mesenchymal transition.$763,886
R01 · FY2025 · HD
Targeting alternative isoform variation for TCR discovery in platinum-resistant ovarian cancer$681,544
R01 · FY2025 · CA
Novel biological insights by utilizing mitochondrial genome information from HuBMAP resources$492,318
U01 · FY2025 · HL
Targeting alternative isoform variation for TCR discovery in platinum-resistant ovarian cancer$695,797
R01 · FY2024 · CA
Novel biological insights by utilizing mitochondrial genome information from HuBMAP resources$505,417
U01 · FY2024 · HL
Novel biological insights by utilizing mitochondrial genome information from HuBMAP resources$517,577
U01 · FY2023 · HL
Identification and cloning of neoantigen-specific T cells for GBM immunotherapy$402,460
R01 · FY2023 · CA
Novel biological insights by utilizing mitochondrial genome information from HuBMAP resources$100,000
U01 · FY2023 · HL
Targeting alternative splicing for TCR discovery in small cell carcinomas$779,998
U01 · FY2022 · CA
Multi-omic analysis of Myc-driven splicing for prostate cancer therapeutic development$634,446
R01 · FY2022 · CA
Computational tools and resources to study alternative splicing and mRNA isoform variation$568,846
R56 · FY2022 · HG · contact PI
Novel biological insights by utilizing mitochondrial genome information from HuBMAP resources$528,000
U01 · FY2022 · HL
Identification and cloning of neoantigen-specific T cells for GBM immunotherapy$402,457
R01 · FY2022 · CA
Targeting alternative splicing for TCR discovery in small cell carcinomas$779,998
U01 · FY2021 · CA
Multi-omic analysis of Myc-driven splicing for prostate cancer therapeutic development$647,398
R01 · FY2021 · CA
Identification and cloning of neoantigen-specific T cells for GBM immunotherapy$410,675
R01 · FY2021 · CA
Targeting alternative splicing for TCR discovery in small cell carcinomas$250,000
U01 · FY2021 · CA
Targeting alternative splicing for TCR discovery in small cell carcinomas$779,998
U01 · FY2020 · CA
Multi-omic analysis of Myc-driven splicing for prostate cancer therapeutic development$647,398
R01 · FY2020 · CA
Elucidating an Xist-dependent program of sexually dimorphic alternative splicing in the mammalian brain$641,663
R01 · FY2020 · MH
Identification and cloning of neoantigen-specific T cells for GBM immunotherapy$410,675
R01 · FY2020 · CA
VARIATION AND REGULATION OF ALTERNATIVE SPLICING IN HUMAN TRANSCRIPTOMES$369,600
R01 · FY2020 · GM · contact PI
Targeting alternative splicing for TCR discovery in small cell carcinomas$779,998
U01 · FY2019 · CA
Elucidating an Xist-dependent program of sexually dimorphic alternative splicing in the mammalian brain$641,663
R01 · FY2019 · MH
Multi-omic analysis of Myc-driven splicing for prostate cancer therapeutic development$627,973
R01 · FY2019 · CA
Identification and cloning of neoantigen-specific T cells for GBM immunotherapy$410,675
R01 · FY2019 · CA
VARIATION AND REGULATION OF ALTERNATIVE SPLICING IN HUMAN TRANSCRIPTOMES$369,600
R01 · FY2019 · GM · contact PI
Targeting alternative splicing for TCR discovery in small cell carcinomas$779,998
U01 · FY2018 · CA
Multi-omic analysis of Myc-driven splicing for prostate cancer therapeutic development$646,360
R01 · FY2018 · CA
Elucidating an Xist-dependent program of sexually dimorphic alternative splicing in the mammalian brain$641,663
R01 · FY2018 · MH
ProteoSeq - An Integrative Computational Framework for Proteotranscriptomics$383,264
R01 · FY2018 · GM · contact PI
VARIATION AND REGULATION OF ALTERNATIVE SPLICING IN HUMAN TRANSCRIPTOMES$228,140
R01 · FY2018 · GM · contact PI
Variation and regulation of alternative splicing in human transcriptomes$121,211
R01 · FY2018 · GM · contact PI
Elucidating an Xist-dependent program of sexually dimorphic alternative splicing in the mammalian brain$641,663
R01 · FY2017 · MH
Genomic and functional analysis of transcriptome changes in Huntington's Disease$589,943
R01 · FY2017 · NS
ProteoSeq - An Integrative Computational Framework for Proteotranscriptomics$351,280
R01 · FY2017 · GM · contact PI
Variation and regulation of alternative splicing in human transcriptomes$323,400
R01 · FY2017 · GM · contact PI
Elucidating an Xist-dependent program of sexually dimorphic alternative splicing in the mammalian brain$712,958
R01 · FY2016 · MH
Genomic and functional analysis of transcriptome changes in Huntington's Disease$606,057
R01 · FY2016 · NS
ProteoSeq - An Integrative Computational Framework for Proteotranscriptomics$364,980
R01 · FY2016 · GM · contact PI
Evolution of Pre-mRNA Splicing in Primates$96,558
R01 · FY2016 · GM · contact PI
Genomic and functional analysis of transcriptome changes in Huntington's Disease$674,688
R01 · FY2015 · NS
Epigenomic control of RNA splicing$308,000
R01 · FY2015 · ES · contact PI
Genomic and functional analysis of transcriptome changes in Huntington's Disease$681,033
R01 · FY2014 · NS
Epigenomic control of RNA splicing$308,000
R01 · FY2014 · ES · contact PI
Evolution of Pre-mRNA Splicing in Primates$289,674
R01 · FY2014 · GM · contact PI
Genomic and functional analysis of transcriptome changes in Huntington's Disease$653,528
R01 · FY2013 · NS
Evolution of Pre-mRNA Splicing in Primates$279,536
R01 · FY2013 · GM · contact PI
Transcriptome in Huntington's disease and Huntington's disease-like 2$150,846
R21 · FY2013 · NS · contact PI
Transcriptome in Huntington's disease and Huntington's disease-like 2$281,814
R21 · FY2012 · NS · contact PI
Evolution of Pre-mRNA Splicing in Primates$155,274
R01 · FY2012 · GM · contact PI
Evolution of Pre-mRNA Splicing in Primates$130,910
R01 · FY2012 · GM · contact PI
Evolution of Pre-mRNA Splicing in Primates$282,150
R01 · FY2011 · GM · contact PI
Altered microRNA function in cystic fibrosis airway epithelia$187,437
R21 · FY2011 · HL
Identification of a metabolic syndrome transcriptome signature in the LH rat$185,625
R21 · FY2011 · DK
Evolution of Pre-mRNA Splicing in Primates$285,000
R01 · FY2010 · GM · contact PI
Identification of a metabolic syndrome transcriptome signature in the LH rat$225,000
R21 · FY2010 · DK · contact PI
Altered microRNA function in cystic fibrosis airway epithelia$223,750
R21 · FY2010 · HL